Prescient Therapeutics Limited Financial Overview
Prescient Therapeutics Limited's market cap is currently AU$90.43M. The company's EPS TTM is AU$-0.006; its P/E ratio is -9.45; Prescient Therapeutics Limited is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
